XML 55 R34.htm IDEA: XBRL DOCUMENT v3.2.0.727
Business Acquisitions (Details) - USD ($)
$ in Millions
1 Months Ended 6 Months Ended 12 Months Ended
Sep. 26, 2014
Sep. 26, 2014
Dec. 31, 2014
Jun. 30, 2015
Dec. 31, 2014
Business acquisitions          
Subsequent payment related to working capital adjustment     $ 5    
Net cash paid, net of cash on hand of acquired company       $ 4  
Minimum          
Allocation of the fair value          
Amortization period of acquired intangible assets       2 years  
Maximum          
Allocation of the fair value          
Amortization period of acquired intangible assets       20 years  
Average          
Allocation of the fair value          
Amortization period of acquired intangible assets       12 years  
CFR Pharmaceuticals SA          
Business acquisitions          
Cash paid for business acquisition $ 2,900        
Net cash paid, net of cash on hand of acquired company 2,800        
Assumed debt 570 $ 570      
Acquisition cost $ 3,400        
Percentage of voting interest acquired 99.90% 99.90%      
Fair value of the non-controlling interest at the acquisition date $ 3 $ 3      
Allocation of the fair value          
Acquired intangible assets, non-deductible 1,800 1,800      
Goodwill, non-deductible   1,600      
Acquired net tangible assets 60 60      
Deferred income taxes recorded at acquisition (540) (540)      
Total preliminary allocation of fair value 2,920 2,920      
Cash and cash equivalents 94 94      
Trade accounts receivable 179 179      
Inventory 169 169      
Other current assets 51 51      
Property and equipment 209 209      
Other long-term assets 138 138      
Borrowings 570 570      
Trade accounts payable and other current liabilities 200 200      
Other noncurrent liabilities 15 $ 15      
Pro forma financial information          
Annualized net sales expected $ 750        
CFR Pharmaceuticals SA | Minimum          
Allocation of the fair value          
Amortization period of acquired intangible assets 12 years        
CFR Pharmaceuticals SA | Maximum          
Allocation of the fair value          
Amortization period of acquired intangible assets 16 years        
CFR Pharmaceuticals SA | Average          
Allocation of the fair value          
Amortization period of acquired intangible assets 15 years        
Veropharm          
Business acquisitions          
Cash paid for business acquisition     $ 315    
Acquisition cost         $ 415
Percentage of voting interest acquired     98.00% 100.00% 98.00%
Fair value of the non-controlling interest at the acquisition date     $ 5   $ 5
Assumed debt     90   90
Allocation of the fair value          
Goodwill, non-deductible     115    
Deferred income taxes recorded at acquisition     $ (25)   (25)
Amortization period of acquired intangible assets     16 years    
Trade accounts receivable     $ 45   45
Inventory     25   25
Property and equipment     165   165
Other current liabilities     10   10
Pro forma financial information          
Non-deductible definite-lived intangible assets     100   100
Topera          
Business acquisitions          
Cash paid for business acquisition     250    
Allocation of the fair value          
Goodwill, non-deductible     175    
Deferred income taxes recorded at acquisition     $ (105)   (105)
Amortization period of acquired intangible assets     16 years    
Pro forma financial information          
Additional payments upon completion of certain development, regulatory and sales milestones     $ 300   300
Non-deductible acquired in-process research and development     20   20
Non-deductible definite-lived intangible assets     325   325
Contingent consideration     $ 165   $ 165